WOONSOCKET, R.I., Feb. 24, 2021 /PRNewswire/ -- CVS Health (NYSE:
CVS) has added Alabama,
Arizona, Florida, Louisiana, Ohio, and Pennsylvania to the list of states where
select CVS Pharmacy locations will offer COVID-19 vaccinations to
eligible populations through the Federal Retail Pharmacy Program.
This follows the successful February
12 rollout in 11 states: California, Connecticut, Hawaii, Maryland, Massachusetts, New
Jersey, New York,
Rhode Island, South Carolina, Texas, and Virginia. Appointments for the latest
allocation of approximately 570,000 doses will start to become
available for booking today, with shots beginning February 25.
"Feedback on every aspect of the vaccination process has been
incredibly positive, from the digital experience to interacting
with our team of health care professionals," said Karen S. Lynch, President and Chief Executive
Officer, CVS Health. "We're also making significant progress in
reaching vulnerable communities, which will continue to be an
essential part of our vaccination effort."
There are nearly 10,000 CVS Pharmacy locations nationwide, with
almost half located in communities ranked high or very high in the
Centers for Disease Control and Prevention Social Vulnerability
Index (SVI). High SVI rank, along with population density and area
demographics, are critical factors when determining which CVS
Pharmacy locations will offer COVID-19 vaccinations. CVS Health
recently announced several steps to address vaccine education
and equity, in particular among Black and Hispanic populations.
CVS Health has been offering COVID-19 vaccines on a limited
basis in Ohio using state
allocations. As more supply becomes available through the federal
program, the company will expand to additional states while
increasing the number of stores offering vaccinations. CVS Pharmacy
has the capacity to administer 20 – 25 million shots per month.
Vaccines in a retail setting are offered on an appointment-only
basis via CVS.com or through the CVS Pharmacy app, and those
without online access can contact customer service: (800)
746-7287.
Long-term care vaccination effort nearing completion
CVS Health has administered approximately four million COVID-19
vaccine doses to residents and staff in over 40,000 long-term care
facilities across the country through the Pharmacy Partnership for
Long-Term Care Program. CVS Pharmacy teams have completed second
doses at all skilled nursing facilities and will complete second
doses at assisted living and other facilities by mid-March,[1]
delivering on the company's commitment to help protect a population
disproportionately impacted by the pandemic. CVS Health has been
regularly updating its progress through publicly available
data.
Multimedia assets, including b-roll and still photography from
long-term care facility and in-store COVID-19 vaccinations, are
available here. More information on steps CVS Health has taken to
address the pandemic is available at the company's frequently
updated COVID-19 resource center.
About CVS Health
CVS Health is a different kind of
health care company. We are a diversified health services company
with nearly 300,000 employees united around a common purpose of
helping people on their path to better health. In an increasingly
connected and digital world, we are meeting people wherever they
are and changing health care to meet their needs. Built on a
foundation of unmatched community presence, our diversified model
engages one in three Americans each year. From our innovative new
services at HealthHUB® locations, to transformative programs that
help manage chronic conditions, we are making health care more
accessible, more affordable and simply better. Learn more about how
we're transforming health at www.cvshealth.com.
Cautionary Statement Concerning Forward-Looking
Statements
The Private Securities Litigation Reform Act of
1995 provides a safe harbor for forward-looking statements made by
or on behalf of CVS Health Corporation. By their nature, all
forward-looking statements are not guarantees of future performance
or results and are subject to risks and uncertainties that are
difficult to predict and/or quantify. Actual results may differ
materially from those contemplated by the forward-looking
statements due to risks and uncertainties described in our
Securities and Exchange Commission ("SEC") filings, including those
set forth in the Risk Factors section and under the heading
"Cautionary Statement Concerning Forward Looking Statements" in our
most recently filed Annual Report on Form 10-K and our Quarterly
Report on Form 10-Q for the quarterly period ended September 30, 2020. You are cautioned not to
place undue reliance on CVS Health's forward looking statements.
CVS Health's forward-looking statements are and will be based upon
management's then-current views and assumptions regarding future
events and operating performance, and are applicable only as of the
dates of such statements. CVS Health does not assume any duty to
update or revise forward-looking statements, whether as a result of
new information, future events, uncertainties or otherwise.
Media contact
T.J. Crawford
212-457-0583
crawfordt2@aetna.com
1 Excludes facilities that 1) requested a later date
due to a COVID-19 outbreak or other reason, 2) were rescheduled due
to lack of responsiveness, or 3) requested to be added to the
program after the start date or did not meet original program
criteria regarding distance from CVS Pharmacy locations, but CVS
Health has opted to support.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cvs-health-will-administer-covid-19-vaccines-in-six-additional-states-301234055.html
SOURCE CVS Health